To include your compound in the COVID-19 Resource Center, submit it here.

MVA-Muc1-IL2 vaccine: Phase II

An interim analysis of a European Phase II trial of MVA-Muc1-IL2

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE